Author:
Locker G.,Mader R.,Steger G.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Andrews PLR, Bailey HE, Hawthorn J, Stables R, Tyers MB: GR38032, a novel 5-HT3 receptor antagonist, can abolish emesis induced by cyclophosphamide or radiation in the ferret. Br J Pharmacol 1987;91:417P.
2. Andrews PLR, Hawthorn J: The neurophysiology of vomiting. Baillieres Clin Gastroenterol 1988;2:141–168.
3. Bermudez J, Boyle EA, Miner WD, Sanger GJ: The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer 1988; 58:644–650.
4. Boyle EA, Miner WD, Sanger GJ: Different anticancer treatments evoke emesis by mechanisms that can be blocked by the 5-HT3 receptor antagonist BRL 43694. Br J Pharmacol 1987;91:418P.
5. Bradley PB, Engel G, Fenuik W, et al: Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986;25:563–575.